Home > Journals > The Journal of Cardiovascular Surgery > Past Issues > The Journal of Cardiovascular Surgery 2021 June;62(3) > The Journal of Cardiovascular Surgery 2021 June;62(3):203-10

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

REVIEW  CURRENT TREND IN THORACOABDOMINAL AORTIC ANEURYSM SURGERY - PART 1 Freefree

The Journal of Cardiovascular Surgery 2021 June;62(3):203-10

DOI: 10.23736/S0021-9509.21.11816-6

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English

Update on the genetic risk for thoracic aortic aneurysms and acute aortic dissections: implications for clinical care

Dianna M. MILEWICZ , Dongchuan GUO, Ellen HOSTETLER, Isabella MARIN, Amelie C. PINARD, Alana C. CECCHI

McGovern Medical School, Division of Medical Genetics, Department of Internal Medicine, University of Texas Health Science Center, Houston, TX, USA



Genetic variation plays a significant role in predisposing individuals to thoracic aortic aneurysms and dissections. Advances in genomic research have led to the discovery of 11 genes validated to cause heritable thoracic aortic disease (HTAD). Identifying the pathogenic variants responsible for aortic disease in affected patients confers substantial clinical utility by establishing a definitive diagnosis to inform tailored treatment and management, and enables identification of at-risk relatives to prevent downstream morbidity and mortality. The availability and access to clinical genetic testing has improved dramatically such that genetic testing is considered an integral part of the clinical evaluation for patients with thoracic aortic disease. This review provides an update on our current understanding of the genetic basis of thoracic aortic disease, practical recommendations for genetic testing, and clinical implications.


KEY WORDS: Genetic therapy; Aneurysm, dissecting; Aortic diseases; Genetic testing

top of page